Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- 15:45 - 16:45
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Moderators:Luis Paz-Ares, Tina Cascone
-
+
Session Moderator
15:45 - 15:45 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
Session Moderator
15:45 - 15:45 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.01 - Session Introduction
15:45 - 15:46 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
MA05.02 - Session Introduction
15:46 - 15:47 | Presenter: Tina Cascone
- Abstract
Loading... -
+
MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer
15:47 - 15:52 | Presenter: Wenbin Li | Author(s): Xiaoxuan Wu, Peng Song, Jianming Ying, Shugeng Gao
- Abstract
Loading... -
+
MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC
15:52 - 15:57 | Presenter: Max Wilhelm Backman | Author(s): Hedvig Elfving, Hans Brunnström, Johanna Mattsson, Johan Isaksson, Linnéa La Fleur, Klas Kärre, Fredrik Pontén, Kristina Lamberg, Cecilia Lindskog, Miklos Gulyas, Carina Strell, Johan Botling, Artur Mezheyeuski, Patrick Micke
- Abstract
Loading... -
+
MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment
15:57 - 16:02 | Presenter: Xiaoli Liu | Author(s): Xue Hu, Yating Zheng
- Abstract
Loading... -
+
MA05.06 - Discussant
16:02 - 16:12 | Presenter: Fabio Pagni
- Abstract
Loading... -
+
MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping
15:57 - 16:02 | Presenter: Yuchen Han | Author(s): Shengnan Chen, Chan Xiang, Lianying Guo, Lei Zhu, Jinchen Shao, Tao Hu, Jin Wang, Changbin Zhu
- Abstract
Loading... -
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Presenter: Jennifer A. Marks | Author(s): Jun Yin, Balazs Halmos, Lyudmila Bazhenova, Suresh S. Ramalingam, Melina Elpi Marmarelis, Joanne Xiu, Phillip Walker, Matthew Oberley, Patrick Ma, Stephen V. Liu
- Abstract
Loading... -
+
MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma
16:22 - 16:27 | Presenter: Harry Lengel
- Abstract
Loading... -
+
MA05.10 - Discussant
16:27 - 16:37 | Presenter: Giulia Pasello
- Abstract
Loading... -
+
MA05.11 - Live Q&A
16:37 - 16:45
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Presenter: Xiuning Le | Author(s): Robyn Du, Whitney Lewis, Lingzhi Hong, Ferdinandos Skoulidis, Lauren Averett Byers, Anne Tsao, Tina Cascone, Jenny Pozadzides, Janet Tu, Marcelo V. Negrao, Christina Baik, JianJun Zhang, John Heymach- Abstract
Loading...
-
+
ES28 - Neoadjuvant and Adjuvant Treatment of NSCLC in 2022
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Systemic Therapy (Multi-Modality Treatment, Immunotherapy, Molecular Targeted Treatments)
- Moderators:Tina Cascone, Mariano Provencio
-
+
Session Moderator
11:35 - 11:45 | Presenter: Tina Cascone
- Abstract
Loading... -
+
Session Moderator
11:35 - 11:45 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES28.01 - Session Introduction
10:45 - 10:46 | Presenter: Tina Cascone
- Abstract
Loading... -
+
ES28.02 - Session Introduction
10:46 - 10:47 | Presenter: Mariano Provencio
- Abstract
Loading... -
+
ES28.03 - Surgical Techniques to Optimize Uptake of Adjuvant Treatment
10:47 - 10:59 | Presenter: Thomas D'Amico
- Abstract
Loading... -
+
ES28.04 - Standardisation of Pathological Assessment with Novel Neoadjuvant Therapies
10:59 - 11:11 | Presenter: Yasushi Yatabe
- Abstract
Loading... -
+
ES28.05 - How Does MRD Status Affect Decisions on Adjuvant Therapy?
11:11 - 11:23 | Presenter: Federico Cappuzzo
- Abstract
Loading... -
+
ES28.06 - Neoadjuvant EGFR TKI Trials
11:23 - 11:35 | Presenter: Julia Rotow
- Abstract
Loading... -
+
ES28.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
